Page 1 - MSM Campaign Council Webinar - June 2021

James W. Lillard, Jr., PhD, MBA Professor in the Department of Microbiology & Immu-
nology at the University of Louisville. Dr. Lillard rejoined
Entrepreneur in Residence | National Academy of Inventors Fellow MSM’s faculty as Professor of Microbiology, Biochemistry,
American Association for the Advancement of Science Fellow & Immunology and Assistant Dean for Research. In July
44 h-index | 75 i10-index 2011, Dr. Lillard established the Office of Translational
Technologies at MSM, where he serves as its Director.
Academic Appointments Since 2018, he has served as the Program Director of the
Associate Dean for Research Affairs, Morehouse School of Medicine online MS in Biotechnology program at MSM, which is
PI, AACR President’s 2020 by 2020 Initiative & Total Cancer Care Protocol now ranked #1 out of 139 similar programs by Intelligent.
com. He is the Program Director of the online MS in
MPI, NCI U54 MSM/TU/UAB CCC Partnership Health Informatics program. Dr. Lillard serves as the Di-
Director, OTT & GRA Ventures at Morehouse School of Medicine rector of the Georgia Research Alliance Ventures Program
Director, online MS Biotechnology and MS Health Informatics Programs and Associate Dean for Research Affairs at Morehouse School of Medicine. He has
Professor, Microbiology, Biochemistry & Immunology helped establish biotech companies and contributed to the formation and commer-
cialization plans of others, as scientific and business advisor and/or founder.
Industry Appointments
President & CEO, JYANT Technologies, Inc. Research Interests
Scientific Advisor, Wellesley Pharmaceuticals, Inc. Dr. Lillard is an immuno-biologist who uses both in silico and in vivo methods to
develop biologics and other technologies to diagnose, prevent, and/or treat cancer
Board of Advisors – Member, DevMar Manufacturing, Inc. and infectious diseases. Most recently, his laboratory research involves dissecting
Scientific Medical Advisory Board – Ciitizen Corporation G protein-coupled receptors effects on cancers progression and immunity. James

James Lillard completed his B.S. degree in Electrical Engineering & Computer Sci- is the principal investigator of the Total Cancer Care protocol, which aggregates
ence from the Ohio State University and worked as a product development engineer and analyzes clinically annotated WGS/WES/WTS data from African American
for IBM. He received his Ph.D. in Microbiology & Immunology from the University cancer patients/survivors to generate medical reports and identify new drug tar-
of Kentucky School of Medicine, where he studied Yersinia “plague” pathogenesis. gets and diagnostic markers, making it the largest initiative of its kind. His research
Dr. Lillard completed post-doctoral training in mucosal immunology at the Univer- contributions span multiple disciplines including oncology, vaccine development,
sity of Alabama at Birmingham. He has worked as an Assistant, Associate, and now and biodefense. Dr. Lillard’s cumulative peer-reviewed funding principally directed
Full Professor in the Department of Microbiology, Biochemistry, and Immunology over his scientific career exceeds $55 million and he has authored over 300 scientific
at Morehouse School of Medicine, University of Louisville School of Medicine, and communications, which have been cited over 8,400 times. Dr. Lillard’s articles have
completed an Executive MBA from the Goizueta Business School at Emory Univer- appeared in International Journal of Cancer Research, Clinical Cancer Research,
sity with a focus on Biotechnology. Journal of Clinical Investigations, Journal Immunology, Laboratory Investigations,
and Proceedings of the National Academy of Sciences USA. His work is well-rec-
Leadership Roles ognized as indicated by his appointment as a NAI Fellow, AAAS Fellow, and service
Dr. Lillard was the Smith & Lucille Gibson Endowed Chair in Medicine, Senior on editorial boards and scientific review for the NIH, VA, DoD, US FDA, industry
Scientist at the James Graham Brown Cancer Center, and Vice Chair for Research & advisory panels and study sections.